New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies

BACKGROUND: Primary aldosteronism (PA) is a common cause of secondary hypertension and associated with higher incidence of new-onset atrial fibrillation (NOAF). However, the effects of surgical or medical therapies on preventing NOAF in PA patents remain unclear. The aim of this meta-analysis study...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Endocrinol (Lausanne)
Asıl Yazarlar: Tsai, Cheng-Hsuan, Chen, Ya-Li, Pan, Chien-Ting, Lin, Yen-Tin, Lee, Po-Chin, Chiu, Yu-Wei, Liao, Che-Wei, Chen, Zheng-Wei, Chang, Chin-Chen, Chang, Yi-Yao, Hung, Chi-Sheng, Lin, Yen-Hung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Endocrinology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181760/
https://ncbi.nlm.nih.gov/pubmed/34108934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.646933
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller